American Association for the Study of Liver Diseases Guidelines: What's New in 2025
Nov
09
2025
Convention Center: Hall A (General Session), Concourse Level
5:00 PM - 6:30 PM
Live Streamed
Captured
World Class Speakers
Description
Prepared by the Practice Guidelines Committee, this session highlights newly published AASLD guidelines addressing critical issues regarding treatment of viral hepatitis B. Speakers also present an extensive list of topics pertaining to liver transplantation in adults ranging from pretransplant evaluation to management of various graft-related and nongraft-related postoperative complications.Journey Maps
Presentations
5:00 PM - 5:15 PM
Nov
09
2025
Washington, D.C.
New Treatment Recommendations for Hepatitis B
Norah Terrault, MD, MPH, FAASLD, Presenter
Hepatitis
MASLD
Public Health
Transplant
5:15 PM - 5:30 PM
Nov
09
2025
Washington, D.C.
Adult Liver Transplantation: Candidate Evaluation
Lorna Dove, MD, MPH, Presenter
Hepatitis
MASLD
Public Health
Transplant
5:30 PM - 5:38 PM
Nov
09
2025
Washington, D.C.
Management of Post Liver Transplant Graft-Related Complications
Helen Te, MD, FAASLD, Presenter
Hepatitis
MASLD
Public Health
Transplant
5:38 PM - 5:45 PM
Nov
09
2025
Washington, D.C.
Management of Post Liver Transplant Graft-Related Complications
Thomas Schiano, MD, FAASLD, Presenter
Hepatitis
MASLD
Public Health
Transplant
5:45 PM - 6:00 PM
Nov
09
2025
Washington, D.C.
Management of Post Liver Transplant Nongraft-Related Complications
Pratima Sharma, MD, MS, Presenter
Hepatitis
MASLD
Public Health
Transplant
6:00 PM - 6:10 PM
Nov
09
2025
Washington, D.C.
MASLD Semaglutide Update
Meena B Bansal, MD, FAASLD, Presenter
Hepatitis
MASLD
Public Health
Transplant
6:10 PM - 6:30 PM
Nov
09
2025
Washington, D.C.
Question and Answer
Jennifer C Price, MD, PhD, Moderator
Hepatitis
MASLD
Public Health
Transplant
Objectives
- Identify the best treatment strategies for people living with chronic hepatitis B.
- Review appropriate selection of adult candidates for liver transplant evaluation.
- Summarize the identification and management of post liver transplant graft-related and nongraft-related complications in adults.
- Provide guidance on the use of semaglutide (Wegovy) for the treatment of MASLD/MASH
Chair
Cynthia Levy, MD, FAASLD
University of Miami